Hypercholesterolemia in the newborn: occurrence after anterpartum treatment with betamethasone-phenobarbital-ritodrine for the prevention of the respiratory distress syndrome.
D001623:Betamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D007236:Infant, Small for Gestational Age; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D010634:Phenobarbital / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011412:Propanolamines / Q000009:adverse effects*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D012312:Ritodrine / Q000009:adverse effects* / Q000627:therapeutic use
D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D011412:Propanolamines; D002784:Cholesterol; D001623:Betamethasone; D012312:Ritodrine; D010634:Phenobarbital